Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial




Velders MA, Wallentin L, Becker RC, Van Boven AJ, Himmelmann A, Husted S, Katus HA, Lindholm D, Morais J, Siegbahn A, Storey RF, Wernroth L, James SK; PLATO Investigators

2015

American Heart Journal

169

6

879

889

11

0002-8703

DOIhttps://doi.org/10.1016/j.ahj.2015.02.019




Last updated on 2024-26-11 at 22:56